// App-Quantinova.ai

AB0737 (2018) : Aminaphtone increases skin blood perfusion and improves clinical symptoms in patients with raynaud’s phenomenon independently from different treatment backgrounds

Researchers

Presenter

  • B. Ruaro

Principal Investigators

  • C. Pizzorni

  • E. Gotelli

  • J. Alsheyyab

  • E. Alessandri

  • A. Sulli

Medical Centers

  • Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Raynaud syndrome

  • Scleroderma

  • Pulmonary alveolar microlithiasis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Cyclosporine A

  • Mycophenolic acid

  • Cyclosporine eent

  • Methotrexate

  • Colchicine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved